These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 9748895)

  • 1. [Multi-organ tuberculosis in a child: diagnosis and therapeutic problems].
    Kurylak D; Smukalska E; Dylewska K; Staszak-Kowalska R
    Wiad Lek; 1998; 51(7-8):378-82. PubMed ID: 9748895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effectiveness of a 9-month regimen of isoniazid alone versus 3- and 4-month regimens of isoniazid plus rifampin for treatment of latent tuberculosis infection in children: results of an 11-year randomized study.
    Spyridis NP; Spyridis PG; Gelesme A; Sypsa V; Valianatou M; Metsou F; Gourgiotis D; Tsolia MN
    Clin Infect Dis; 2007 Sep; 45(6):715-22. PubMed ID: 17712755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Tuberculosis: a disease that is difficult to eradicate. Description of a case].
    Stazi C; Stazi F
    Clin Ter; 1990 Jul; 134(1):3-12. PubMed ID: 2147606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long term follow up of HIV-infected patients with tuberculosis treated with 6-month intermittent short course chemotherapy.
    Swaminathan S; Deivanayagam CN; Rajasekaran S; Venkatesan P; Padmapriyadarsini C; Menon PA; Ponnuraja C; Dilip M
    Natl Med J India; 2008; 21(1):3-8. PubMed ID: 18472696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved adherence and less toxicity with rifampin vs isoniazid for treatment of latent tuberculosis: a retrospective study.
    Page KR; Sifakis F; Montes de Oca R; Cronin WA; Doherty MC; Federline L; Bur S; Walsh T; Karney W; Milman J; Baruch N; Adelakun A; Dorman SE
    Arch Intern Med; 2006 Sep; 166(17):1863-70. PubMed ID: 17000943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tuberculosis peritonitis.
    DiMase JD; Agrawal D
    Med Health R I; 2007 Nov; 90(11):363-4. PubMed ID: 18092489
    [No Abstract]   [Full Text] [Related]  

  • 7. Tuberculosis presenting as immune thrombocytopenic purpura.
    Spedini P
    Haematologica; 2002 Feb; 87(2):ELT09. PubMed ID: 11836186
    [No Abstract]   [Full Text] [Related]  

  • 8. Latent tuberculosis infection in children: a call for revised treatment guidelines.
    Finnell SM; Christenson JC; Downs SM
    Pediatrics; 2009 Mar; 123(3):816-22. PubMed ID: 19255008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-course therapy with rifampin plus isoniazid, compared with standard therapy with isoniazid, for latent tuberculosis infection: a meta-analysis.
    Ena J; Valls V
    Clin Infect Dis; 2005 Mar; 40(5):670-6. PubMed ID: 15714411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Revised treatment and testing guidelines for latent tuberculosis infection.
    Rep Med Guidel Outcomes Res; 2000 Apr; 11(9):9-10. PubMed ID: 11770514
    [No Abstract]   [Full Text] [Related]  

  • 11. Update on the treatment of tuberculosis.
    Inge LD; Wilson JW
    Am Fam Physician; 2008 Aug; 78(4):457-65. PubMed ID: 18756652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary esophageal tuberculosis: a case report and 1996 update.
    Trehan AK
    Am J Gastroenterol; 1996 Jun; 91(6):1286-7. PubMed ID: 8651207
    [No Abstract]   [Full Text] [Related]  

  • 13. [Case of liver tuberculosis requiring differentiation from liver metastasis of cancer].
    Kobayashi K; Yano S; Ikeda T; Tokuda Y; Touge H; Ishikawa S; Takeyama H
    Kekkaku; 2007 Mar; 82(3):185-8. PubMed ID: 17444122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-course rifampin and pyrazinamide compared with isoniazid for latent tuberculosis infection: a cost-effectiveness analysis based on a multicenter clinical trial.
    Jasmer RM; Snyder DC; Saukkonen JJ; Hopewell PC; Bernardo J; King MD; Kawamura LM; Daley CL;
    Clin Infect Dis; 2004 Feb; 38(3):363-9. PubMed ID: 14727206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A severe form of urinary tuberculosis in children].
    Erreimi N; Hida M; Mouane N; Bouchta F
    Ann Urol (Paris); 1997; 31(4):177-80. PubMed ID: 9412338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experimental evidence for Mycobacterium tuberculosis persistence in M. tuberculosis-infected H37RV mice in the treatment with 3 first-line drugs (rifampicin, isoniazid, pyrazinamide)].
    Smirnova TG; Chernousova LN; Andreevskaia SN; Nikolaeva GM
    Probl Tuberk Bolezn Legk; 2004; (3):32-7. PubMed ID: 15338898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chemotherapy of extrapulmonary tuberculosis].
    Zhang YS
    Zhonghua Jie He He Hu Xi Za Zhi; 1991 Jun; 14(3):181-3. PubMed ID: 1913971
    [No Abstract]   [Full Text] [Related]  

  • 18. Mycobacterium tuberculosis presenting as chronic red eye.
    Jennings A; Bilous M; Asimakis P; Maloof AJ
    Cornea; 2006 Oct; 25(9):1118-20. PubMed ID: 17133069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-tuberculosis 4FDC tablets--mystery to chemistry.
    Dekker TG; Lötter AP
    Int J Tuberc Lung Dis; 2003 Mar; 7(3):205-6. PubMed ID: 12661831
    [No Abstract]   [Full Text] [Related]  

  • 20. Comprehensive findings on clinical, bacteriological, histopathological and therapeutic aspects of cutaneous tuberculosis.
    Umapathy KC; Begum R; Ravichandran G; Rahman F; Paramasivan CN; Ramanathan VD
    Trop Med Int Health; 2006 Oct; 11(10):1521-8. PubMed ID: 17002726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.